A representative from the
Vitiligo Society will be speaking at the event at Blossoms Bar, in Wolverhampton on October 20.
The global
vitiligo drugs market size was valued at US$ 120.6 million in 2017, and is expected to exhibit a CAGR of 8.4% over the forecast period (2018-2026).
With all four doses of ruxolitinib in the cream formulation evaluated, significantly more patients with
vitiligo had at least 50% facial repigmentation, compared with vehicle alone, said David Rosmarin, MD, speaking in a late-breaking abstracts session at the World Congress of Dermatology.
My partner has only ever known me with
vitiligo, and it doesn't matter to him.
Vitiligo is an autoimmune skin disease which can be identified by skin depigmentation due to the destruction of melanin cells in the body due to which skin loses its original color, and white spots occur.
Vitiligo is an idiopathic, often heritable, acquired depigmenting disorder of skin characterized by, progressive, circumscribed hypomelanosis of the skin and hair, with total absence of melanocytes microscopically1-2.
- US-based biopharmaceutical company Incyte (NASDAQ: INCY) has received 24-week results from its randomized, double-blind, dose-ranging, vehicle-controlled, Phase 2 study evaluating ruxolitinib cream, a nonsteroidal, anti-inflammatory, JAK inhibitor therapy, in adult patients (18 to 75 years of age) with
vitiligo, the company said.
Even recent studies have suggested that thyroid autoimmunity would trigger and affect the depigmentation process of
vitiligo (8).
The latest magazine issue features fashion star Winnie Harlow and her look-alike Shahad Salman, both models championing
vitiligo awareness.
In his book 'Take control of your health (2007)' Dr Joseph Mercola said
vitiligo was a physical skin condition where the skin loses pigmentation, which created white spots on the skin that could burn more easily in the sun.
Commenting underneath the image, user Bethh96x said: "I have
vitiligo too and it's on most parts of my body.
Vitiligo is the most common pigmentary dermatologic disease caused by the destruction of melanocytes.1-3 Different studies have reported a prevalence of 0.1-2% for this condition.4 Although, pathogenesis of the
vitiligo is not well-known exactly, but genetic predisposition, autoimmunity and neurological theories have been proposed.5-8 Although
vitiligo is not life-threating or symptomatic, it can alter the individual's quality of life and may lead to mental and psychological problem in childhood, and interfere with the treatment adherence process.3